Related references
Note: Only part of the references are listed.Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats
Chia Hui Apphia Eu et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review
Piotr Socha et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
Wai Yen Alfred Lim et al.
LIPIDS IN HEALTH AND DISEASE (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Prevention of free fatty acid-induced hepatic lipotoxicity by 18 beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways
Xudong Wu et al.
HEPATOLOGY (2008)
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
Deepak N. Amarapurkar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines
Shivakumar Chitturi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice
Fumiki Aoki et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): A randomized pilot study
Nilesh Chande et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
IJ Hickman et al.
GUT (2004)
Apolipoprotein synthesis in nonalcoholic steatohepatitis
N Charlton et al.
HEPATOLOGY (2002)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi et al.
HEPATOLOGY (2002)
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with Type II diabetes
S Bernard et al.
DIABETOLOGIA (2000)
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
JE Lavine
JOURNAL OF PEDIATRICS (2000)